Showing results (351-360 of 842) with videos related to
Sort By:
Pageof 85
Nucleic Acids Research|February 22, 2003
Sequence-specific minor groove binding by bis-benzimidazoles: water molecules in ligand recognitionChristian Bailly, Gianni Chessari, Carolina Carrasco, et al.Sexual Health|July 30, 2016
Syphilis: a fresh look at an old foeMarcus Y Chen, Jeffrey D Klausner, Christopher Kit Fairley, et al.Biochemistry|April 16, 2020
Extending the σ-Hole Motif for Sequence-Specific Recognition of the DNA Minor GroovePu Guo, Abdelbasset A Farahat, Ananya Paul, et al.Transactions of the American Ophthalmological Society|May 2, 2007
Persistent placoid maculopathy: a new clinical entityPamela R Golchet, Lee M Jampol, David Wilson, et al.Drug Safety|July 1, 2020
Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial ProgrammeKaren Cheng, Paul Newell, Joseph W Chow, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|February 24, 2015
Resolution of mixed site DNA complexes with dimer-forming minor-groove binders by using electrospray ionization mass spectrometry: compound structure and DNA sequence effectsSarah Laughlin, Siming Wang, Arvind Kumar, et al.Genetics, Selection, Evolution : GSE|July 10, 2020
Extending long-range phasing and haplotype library imputation algorithms to large and heterogeneous datasetsDaniel Money, David Wilson, Janez Jenko, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 9, 2005
Racial differences in rate of decline in bone mass in older men: the Baltimore men's osteoporosis studyJ Kathleen Tracy, Walter A Meyer, Raymond H Flores, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 11, 2026
Comparison of a multi-analyte algorithmic immunoassay blood test with immunoprecipitation mass spectrometry for the detection of amyloid pathologyDavid Wilson, Karen Copeland, Lindsey Mette, et al.Clinical Therapeutics|August 19, 2007
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trialRichard Berger, Ronald Rizer, Alicia Barba, et al.Pageof 85